Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Wilate in Previously Treated Paediatric Patients With Severe Haemophilia A
Phase of Trial: Phase III
Latest Information Update: 30 Nov 2018
Price : $35 *
At a glance
- Drugs Factor VIII/von Willebrand factor (Primary)
- Indications Haemophilia A
- Focus Pharmacokinetics
- Sponsors Octapharma
- 22 Nov 2018 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 24 Jul 2018 Planned End Date changed from 1 Aug 2018 to 1 Nov 2018.